tiprankstipranks
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
PremiumPress ReleasesQIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
10d ago
Is QGEN a Buy, Before Earnings?
PremiumPre-Earnings
Is QGEN a Buy, Before Earnings?
13d ago
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
PremiumPress Releases
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
15d ago
QIAGEN announces Form 20-F annual report filing for 2023 results
PremiumPress ReleasesQIAGEN announces Form 20-F annual report filing for 2023 results
2M ago
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
PremiumPress Releases
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
2M ago
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
PremiumPress Releases
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100